The researchers will test 300 children and adolescents aged 6 to 17 in three cities in the UK, in order to assess whether the vaccine is safe and whether it produces an immune response in children and adolescents
The Astrazenica vaccine
Photo:
Reuters
The safety and efficacy of the Astraznica and Oxford University vaccines in children should be tested in a new clinical trial, which will begin later this month.
This was reported today (Saturday).
The researchers will test a total of 300 testers in three cities in the UK - London, Southampton and Bristol.
This is in order to assess whether the vaccine produces a strong immune response in children aged 6 to 17. This is the first vaccine for Corona to be tested for its safety and efficacy in children and adolescents.
According to the University of Oxford, the experiments conducted so far have focused only on 17-16 year olds.
Watch: Development of the Astraznica vaccine and administration of a vaccine to experimenters // Archive photo: Reuters
It should be noted that Israel has reached an agreement with Astrazenica for the purchase of millions of vaccines, but at this stage the Ministry of Health has not yet approved the use of the vaccine, as the US Food and Drug Administration (FDA) has not yet approved it.
In addition, there is currently a sufficient stock of Pfizer vaccines in Israel, in which clinical trials and even field results show that their effectiveness is higher than that of the Asterzanica vaccine.